Philips Launches next Generation Wearable Biosensor for Early Patient Deterioration Detection, Including Clinical Surveillance for COVID-19

Amsterdam, the Netherlands, May 26 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital. The next generation wireless [...]